Kirk Allen Coleman - 22 Mar 2023 Form 4 Insider Report for TFF Pharmaceuticals, Inc.

Role
Chief Financial Officer
Signature
/s/ Kirk Allen Coleman
Issuer symbol
N/A
Transactions as of
22 Mar 2023
Net transactions value
$0
Form type
4
Filing time
24 Mar 2023, 18:03:40 UTC
Previous filing
13 Mar 2023
Next filing
15 Aug 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TFFP Stock Options (Right to Buy) Award $0 +100,000 $0.000000 100,000 22 Mar 2023 Common Stock 100,000 $0.8000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Options are granted under TFF Pharmaceuticals, Inc. 2021 Stock Incentive Plan. The Options shall vest and first become exercisable as follows: one-quarter of the Options shall vest and first become exercisable on March 22, 2024 and the remainder of the Options shall vest and first become exercisable in 12 equal quarterly installments commencing on June 22, 2024.